Estimating kinetic parameters from dynamic contrast-enhanced T1- weighted MRI of a diffusable tracer: Standardized quantities and symbols

Journal of Magnetic Resonance Imaging

Volumn 10, Issue 3, 1999, Pages 223-232

  Tofts, Paul S ^a   Brix, Gunnar ^b   Buckley, David L ^c   Evelhoch, Jeffrey L ^d   Henderson, Elizabeth ^e   Knopp, Michael V ^f   Larsson, Henrik B W ^g   Lee, Ting Yim ^e   Mayr, Nina A ^h   Parker, Geoffrey J M ^a   Port, Ruediger E ^f   Taylor, June ⁱ   Weisskoff, Robert M ^j  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b BUNDESAMT FÜR STRAHLENSCHUTZ   (Germany)

^c UNIVERSITY OF FLORIDA   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ROBARTS RESEARCH INSTITUTE   (Canada)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g HVIDOVRE HOSPITAL   (Denmark)

^h UNIVERSITY OF IOWA   (United States)

ⁱ ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^j HARVARD UNIVERSITY   (United States)

more..

Author keywords

Extravascular extracellular space; Gd DTPA; Perfusion; Permeability; Rate constant; Transfer constant

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

CONTRAST ENHANCEMENT; DISTRIBUTION VOLUME; DRUG DIFFUSION; DRUG PENETRATION; EXTRACELLULAR SPACE; EXTRAVASCULAR SPACE; HUMAN; NOMENCLATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAMETER; PRIORITY JOURNAL; REVIEW; STANDARDIZATION; TISSUE BLOOD FLOW; TISSUE PERFUSION;

CONTRAST MEDIA; DIFFUSION; EXTRACELLULAR SPACE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MODELS, BIOLOGICAL; TERMINOLOGY;

EID: 0032828135     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S     Document Type: Review

References (50)

1. Mitchell DG. MR imaging contrast agents - what's in a name? J Magn Reson Imaging 1997;7:1-4.
2. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91-101.
3. Kety SS. The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev 1951;3:1-41.
4. Renkin EM. Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am J Physiol 1959;197:1205-1210.
5. Crone C. The permeability of capillaries in various organs as determined by use of the 'indicator diffusion' method. Acta Physiol Scand 1963;58:292-305.
6. Patlak CS, Fenstermacher JD. Measurements of dog blood-brain transfer constants by ventriculocisternal perfusion. Am J Physiol 1975;229:877-884.
7. Ohno K, Pettigrew KD, Rapoport SI. Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. Am J Physiol 1978;235:H299-H307.
8. 11C] butanol. J Cereb Blood Flow Metab 1987;7:527-542.
9. Evelhoch JL. Tracer measurements of blood flow. In Gillies R, editor. NMR in physiology and biomedicine. San Diego: Academic Press; 1994. p 209-220.
10. Notari RE. Biopharmaceutics and clinical pharmaceutics, 4th ed. New York: Marcel Dekker; 1987.
11. Rowland M, Tozer TN. Clinical pharmacokinetics: concepts and applications, 2nd ed. Philadelphia; Williams & Wilkins; 1994.
12. Fenstermacher JD, Blasberg RG, Patlak CS. Methods for quantifying the transport of drugs across brain barrier systems. Pharmacol Ther 1981;14:217-248.
13. St. Lawrence KS, Lee T-Y. An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: I. Theoretical derivation. J Cereb Blood Flow Metab 1998;18:1365-1377.
14. He ZQ, Eveloch JL. Analysis of dynamic contrast-enhanced MRI in tumors: relationship of derived parameters with physiologic factors. ISMRM Sydney 1998;3:1652.
15. Parker GJM, Tofts PS. Pharmacokinetic analysis of neoplasms using contrast-enhanced dynamic MR imaging. Top Magn Reson Imaging 1999 (in press).
16. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging - 1. Fundamental concepts. Magn Reson Med 1991;17:357-367.
17. Larsson HBW, Fritz-Hansen T, Rostrup E, et al. Myocardial perfusion modelling using MRI. Magn Reson Med 1996;35:716-726.
18. Johnson JA, Wilson TA. A model for capillary exchange. Am J Physiol 1966;210:1299-1303.
19. Tofts PS, Berkowitz B, Schnall M. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumours using a permeability model. Magn Reson Med 1995;33:564-568.
20. Larsson HBW, Stubgaard M, Frederiksen JL, et al. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 1990;16:117-131.
21. Larsson HBW, Christiansen P, Stubgaard M, et al. In-vivo calculation of the unidirectional influx constant across the blood-brain barrier using MRI. In: Proceedings of the SMRM 9th Annual Meeting, New York, 1990;2:752.
22. Fritz-Hansen T, Rostrup E, Sondergaard L, et al. Capillary transfer constant of Gd-DTPA in the myocardium at rest and during vasodilation assessed by MRI. Magn Reson Med 1998;40:922-929.
23. Brix G, Semmler W, Port R, et al. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991;15:621-628.
24. Hoffmann U, Brix G, Knopp MV, Hess T, Lorenz WJ. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med 1995;33:506-514.
25. Port RE, Knopp MV, Hoffmann U, Milker-Zabel S, Brix G. Multicompartment analysis of gadolinium chelate kinetics: blood-tissue exchange in mammary tumors as monitored by dynamic MR imaging. J Magn Reson Imaging 1999;10:233-242.
26. Gowland P, Mansfield P, Bullock P, et al. Dynamic studies of gadolinium uptake in brain tumors using inversion-recovery echoplanar imaging. Magn Reson Med 1992;26:2412-258.
27. Daldrup H, Shames DM, Wendland M, et al. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: correlation of macromolecular and small-molecular contrast media. AJR 1998;171:941-949.
28. Daldrup H, Shames DM, Husseini W, et al. Quantification of the extraction fraction of gadopentetate across breast tumor capillaries. Magn Reson Med 1998;40:537-543.
29. Hulka CA, Smith BL, Sgroi DC, et al. Benign and malignant breast lesions: differentiation with echo-planar MR imaging. Radiology 1995;197:33-38.
30. Hulka CA, Edmister WB, Smith BL, et al. Dynamic echo-planar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis. Radiology 1997;205:837-842.
31. Mussurakis S, Buckley DL, Drew PJ, et al. Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumors. Clin Radiol 1997;52:516-526.
32. Turnbull LW, Buckley DL, Turnbull LS, Liney GP, Knowles AJ. Differentiation of prostatic carcinoma and benign prostatic hyperplasia: correlation between dynamic Gd-DTPA enhanced MR imaging and histopathology. J Magn Reson Imaging 1999;9:311-316.
33. Henderson E, Sykes J, Drost D, et al. Measurement of blood flow, blood volume and capillary permeability in a canine spontaneous breast tumour model using two different contrast agents. In: Proceedings of the ISMRM 7th Annual Meeting, Philadelphia, 1999;1:148.
34. Brix G, Bahner ML, Hoffmann U, Horvath A, Schreiber W. Regional blood flow, capillary permeability, and compartmental volumes: measurement with dynamic CT - initial experience. Radiology 1999; 210:269-276.
35. Donahue KM, Weisskoff RM, Burnstein D. Water diffusion and exchange as they influence contrast enhancement. J Magn Reson Imaging 1997;7:102-110.
36. Judd RM, Reeder SB, May-Newman K. Effects of water exchange on the measurement of myocardial perfusion using paramagnetic contrast agents. Magn Reson Med 1999;41:334-342.
37. Mayr NA, Yuh WTC, Magnotta VA, et al. Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new non-invasive predictive assay. Int J Radial Oncol Biol Phys 1996;36:623-633.
38. Mayr NA, Yuh WTC, Arnholt JC, et al. Pixel analysis of dynamic contrast MR and [O-15]water PET studies in cervical cancer-significance for tumor heterogeneity and therapy outcome. Radiology 1997;205(P):525.
39. Mayr NA, Yuh WTC, Zheng J, et al. Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging. Am J Roentgenol 1998;170:177-182.
40. Fujii K, Fujita N, Hirabuki H, et al. Neuromas and meningiomas: evaluation of early enhancement with dynamic MR imaging. AJNR 1992;13:1215-1220.
41. Maeda M, Itoh S, Kimura H, et al. Tumor vascularity in the brain: evaluation with dynamic susceptibility contrast MR imaging. Radiology 1993;189:233-238.
42. Henderson E, Rutt BK, Lee T-Y. Temporal sampling requirements for the tracer kinetics modelling breast disease. J Magn Reson Imaging 1998;16:1057-1073.
43. Tofts PS. Standardisation and optimisation of magnetic resonance techniques for multicentre studies. J Neurol Neurosurg Psychiatry 1998;64 (suppl 1):S37-43.
44. Ianotti F, Fieschi C, Alfano B, et al. Simplified, noninvasive PET measurement of blood-brain barrier permeability. J Comput Assist Tomogr 1987;11:390-397.
45. Yeung WTI, Lee TY, del Maestro RF, Kozak R, Brown T. In vivo CT measurement of blood-brain transfer constant of iopamidol in human brain tumors. J Neuro-Oncol 1992;14:177-187.
46. Larsson HBW, Stubgaard M, Sondergaard L, Henriksen O. In vivo quantification of the unidirectional influx constant for Gd-DTPA diffusion across the myocardial capillaries with MR imaging. J Magn Reson Imaging 1994;4:433-440.
47. Port RE, Bachert P, Semmler W. Kinetic modeling of in vivonuclearmagnetic resonance spectroscopy data: 5-Fluorouracil in liver and liver tumors. Clin Pharmacol Ther 1991;9:497-505.
48. Kety SS. Peripheral blood flow measurement, In: Year Book Medical Publishers; Potter VR, editor. Methods in medical research, vol. 8. 1960. p 223-227.
49. 68Ga]EDTA and positron computed tomography. J Cereb Blood Flow Metab 1984;4:507-515.
50. Yuh WTC. An exciting and challenging role for the advanced contrast MR imaging. J Magn Reson Imaging 1999;10:221-222.